Biotech Scholar Rock to webcast Jefferies healthcare talk June 3
Scholar Rock (NASDAQ: SRRK) announced that its management will participate in the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026, at 11:40 a.m. ET. The company, which specializes in therapies for spinal muscular atrophy and other neuromuscular diseases, will provide a live webcast of the presentation. A replay will also be available on Scholar Rock's investor relations website for approximately 90 days following the event.
MAY 8·GuruFocus→
SRRK Maintained by Barclays -- Price Target Raised to $55
Barclays analyst Etzer Darout has raised the price target for Scholar Rock Holding (SRRK) to $55, maintaining an Overweight rating due to the company's progress in developing therapies for rare neuromuscular diseases. Despite this positive outlook, the company has a low GF Score™ of 31/100, indicating financial weaknesses, and has seen significant insider selling worth $5.0 million over the last three months. Investors are advised to consider these mixed signals cautiously.
MAR 17·MarketBeat▲
2,461,596 Shares in Scholar Rock Holding Corporation $SRRK Bought by Holocene Advisors LP
Holocene Advisors LP has acquired a new stake of 2,461,596 shares in Scholar Rock Holding Corporation (NASDAQ:SRRK) valued at $91.67 million during the third quarter. This acquisition makes Holocene Advisors LP owner of approximately 2.56% of Scholar Rock's stock. Other institutional investors have also increased their holdings in SRRK, while company insiders have recently sold shares.
